BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25045917)

  • 1. Targeting both viral and host determinants of human immunodeficiency virus entry, using a new lentiviral vector coexpressing the T20 fusion inhibitor and a selective CCL5 intrakine.
    Petit N; Dorgham K; Levacher B; Burlion A; Gorochov G; Marodon G
    Hum Gene Ther Methods; 2014 Aug; 25(4):232-40. PubMed ID: 25045917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer of two entry inhibitors protects CD4⁺ T cell from HIV-1 infection in humanized mice.
    Petit NY; Baillou C; Burlion A; Dorgham K; Levacher B; Amiel C; Schneider V; Lemoine FM; Gorochov G; Marodon G
    Gene Ther; 2016 Feb; 23(2):144-50. PubMed ID: 26488891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection.
    Schroers R; Davis CM; Wagner HJ; Chen SY
    Gene Ther; 2002 Jul; 9(13):889-97. PubMed ID: 12080383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HIV type 1 activity of wild-type and functional defective RANTES intrakine in primary human lymphocytes.
    Yang AG; Zhang X; Torti F; Chen SY
    Hum Gene Ther; 1998 Sep; 9(14):2005-18. PubMed ID: 9759928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
    Tang X; Jin H; Chen Y; Li L; Zhu Y; Chong H; He Y
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protection of Lymphocytes Against HIV using Lentivirus Vector Carrying a Combination of TRIM5α-HRH Genes and microRNA Against CCR5].
    Omelchenko DO; Glazkova DV; Bogoslovskaya EV; Urusov FA; Zhogina YA; Tsyganova GM; Shipulin GA
    Mol Biol (Mosk); 2018; 52(2):294-305. PubMed ID: 29695698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible expression of the deltaNGFr/F12Nef fusion protein as a new tool for anti-human immunodeficiency virus type 1 gene therapy.
    Muratori C; Schiavoni I; Melucci-Vigo G; Olivetta E; Santarcangelo AC; Pugliese K; Verani P; Federico M
    Hum Gene Ther; 2002 Sep; 13(14):1751-66. PubMed ID: 12396627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of RANTES-KDEL on inhibition of HIV-1 in CD34(+) human hematopoietic stem cells (hHSC).
    Sun L; Zhang Y; Huang CX; Qu XL; Zhang Y; Zhang JC; Wei X; Zhuang Y; Zhai S; Peng MJ; Jiang H; Hao CQ; Li YH; Lu J; Lian JQ; Sun YT; Bai XF
    J Virol Methods; 2008 Dec; 154(1-2):194-9. PubMed ID: 18706447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.
    Takashima K; Miyake H; Furuta RA; Fujisawa JI; Iizawa Y; Kanzaki N; Shiraishi M; Okonogi K; Baba M
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3538-43. PubMed ID: 11709336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Delivered Entry Inhibitors for HIV-1: CCR5 Downregulation and Blocking Virus/Membrane Fusion in Defending the Host Cell Population.
    Symonds G; Bartlett JS; Kiem HP; Tsie M; Breton L
    AIDS Patient Care STDS; 2016 Dec; 30(12):545-550. PubMed ID: 27905841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46.
    Ledger S; Howe A; Turville S; Aggarwal A; Savkovic B; Ong A; Wolstein O; Boyd M; Millington M; Gorry PR; Murray JM; Symonds G
    J Gene Med; 2018 Feb; 20(2-3):e3006. PubMed ID: 29552747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection.
    Kimpel J; Braun SE; Qiu G; Wong FE; Conolle M; Schmitz JE; Brendel C; Humeau LM; Dropulic B; Rossi JJ; Berger A; von Laer D; Johnson RP
    PLoS One; 2010 Aug; 5(8):e12357. PubMed ID: 20808813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
    Chang LJ; Liu X; He J
    Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy.
    Anderson JS; Javien J; Nolta JA; Bauer G
    Mol Ther; 2009 Dec; 17(12):2103-14. PubMed ID: 19690520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of HIV-1 infection in primary CD4 T cells transduced with a self-inactivating lentiviral vector encoding a membrane expressed gp41-derived fusion inhibitor.
    Perez EE; Riley JL; Carroll RG; von Laer D; June CH
    Clin Immunol; 2005 Apr; 115(1):26-32. PubMed ID: 15870017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments.
    Duan L; Zhu M; Bagasra O; Pomerantz RJ
    Hum Gene Ther; 1995 Dec; 6(12):1561-73. PubMed ID: 8664381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
    Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection.
    Wang W; Ye C; Liu J; Zhang D; Kimata JT; Zhou P
    PLoS One; 2014; 9(12):e115987. PubMed ID: 25541967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication.
    Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G
    J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.